Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

QT prolongation in non-telemetered hospitalized elderly patients.

Bajrangee A, Mahabir S, Khalifa W, Maree AO, McAdam B.

J Electrocardiol. 2019 May 21;55:91-96. doi: 10.1016/j.jelectrocard.2019.05.009. [Epub ahead of print] No abstract available.

PMID:
31152997
2.

Next steps in studying the human microbiome and health in prospective studies, Bethesda, MD, May 16-17, 2017.

Sinha R, Ahsan H, Blaser M, Caporaso JG, Carmical JR, Chan AT, Fodor A, Gail MH, Harris CC, Helzlsouer K, Huttenhower C, Knight R, Kong HH, Lai GY, Hutchinson DLS, Le Marchand L, Li H, Orlich MJ, Shi J, Truelove A, Verma M, Vogtmann E, White O, Willett W, Zheng W, Mahabir S, Abnet C.

Microbiome. 2018 Nov 26;6(1):210. doi: 10.1186/s40168-018-0596-z.

3.

The International Childhood Cancer Cohort Consortium (I4C): A research platform of prospective cohorts for studying the aetiology of childhood cancers.

Tikellis G, Dwyer T, Paltiel O, Phillips GS, Lemeshow S, Golding J, Northstone K, Boyd A, Olsen S, Ghantous A, Herceg Z, Ward MH, Håberg SE, Magnus P, Olsen J, Ström M, Mahabir S, Jones RR, Ponsonby AL, Clavel J, Charles MA, Trevathan E, Qian ZM, Maule MM, Qiu X, Hong YC, Brandalise S, Roman E, Wake M, He JR, Linet MS; International Childhood Cancer Cohort Consortium.

Paediatr Perinat Epidemiol. 2018 Nov;32(6):568-583. doi: 10.1111/ppe.12519. Epub 2018 Nov 22. Erratum in: Paediatr Perinat Epidemiol. 2019 Mar;33(2):181.

PMID:
30466188
4.

Short exposure to low concentrations of alcohol during embryonic development has only subtle and strain- dependent effect on the levels of five amino acid neurotransmitters in zebrafish.

Mahabir S, Chatterjee D, Gerlai R.

Neurotoxicol Teratol. 2018 Jul - Aug;68:91-96. doi: 10.1016/j.ntt.2018.05.005. Epub 2018 Jun 7.

PMID:
29886245
5.

Lasting changes induced by mild alcohol exposure during embryonic development in BDNF, NCAM and synaptophysin-positive neurons quantified in adult zebrafish.

Mahabir S, Chatterjee D, Misquitta K, Chatterjee D, Gerlai R.

Eur J Neurosci. 2018 Jun;47(12):1457-1473. doi: 10.1111/ejn.13975. Epub 2018 Jun 15.

6.

Efficacy and safety of sarolaner against generalized demodicosis in dogs in European countries: a non-inferiority study.

Becskei C, Cuppens O, Mahabir SP.

Vet Dermatol. 2018 Jun;29(3):203-e72. doi: 10.1111/vde.12526. Epub 2018 Feb 8.

PMID:
29423956
7.

Efficacy and safety of sarolaner in the treatment of canine ear mite infestation caused by Otodectes cynotis: a non-inferiority study.

Becskei C, Cuppens O, Mahabir SP.

Vet Dermatol. 2018 Apr;29(2):100-e39. doi: 10.1111/vde.12521. Epub 2018 Feb 1.

PMID:
29392787
8.

Research Strategies for Nutritional and Physical Activity Epidemiology and Cancer Prevention.

Mahabir S, Willett WC, Friedenreich CM, Lai GY, Boushey CJ, Matthews CE, Sinha R, Colditz GA, Rothwell JA, Reedy J, Patel AV, Leitzmann MF, Fraser GE, Ross S, Hursting SD, Abnet CC, Kushi LH, Taylor PR, Prentice RL.

Cancer Epidemiol Biomarkers Prev. 2018 Mar;27(3):233-244. doi: 10.1158/1055-9965.EPI-17-0509. Epub 2017 Dec 18. Review.

9.

Evaluation of the efficacy of ProHeart® 6 (moxidectin) against a resistant isolate of Dirofilaria immitis (JYD-34) in dogs.

Bowman DD, McTier TL, Adams EL, Mahabir SP, Login JA, Bidgood T, Woods DJ.

Parasit Vectors. 2017 Nov 9;10(Suppl 2):502. doi: 10.1186/s13071-017-2431-y.

10.

A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client-owned dogs with atopic dermatitis.

Moyaert H, Van Brussel L, Borowski S, Escalada M, Mahabir SP, Walters RR, Stegemann MR.

Vet Dermatol. 2017 Dec;28(6):593-e145. doi: 10.1111/vde.12478. Epub 2017 Sep 14.

PMID:
28906040
11.

Effects of low-to-moderate alcohol supplementation on urinary estrogen metabolites in postmenopausal women in a controlled feeding study.

Mahabir S, Pfeiffer R, Xu X, Baer DJ, Taylor PR.

Cancer Med. 2017 Oct;6(10):2419-2423. doi: 10.1002/cam4.1153. Epub 2017 Sep 6.

12.

Evaluation of the efficacy of sarolaner (Simparica®) in the prevention of babesiosis in dogs.

Geurden T, Six R, Becskei C, Maeder S, Lloyd A, Mahabir S, Fourie J, Liebenberg J.

Parasit Vectors. 2017 Sep 6;10(1):415. doi: 10.1186/s13071-017-2358-3.

13.

The Importance of Holding Water: Salinity and Chemosensory Cues Affect Zebrafish Behavior.

Mahabir S, Gerlai R.

Zebrafish. 2017 Oct;14(5):444-458. doi: 10.1089/zeb.2017.1472. Epub 2017 Sep 5.

PMID:
28873052
14.

Response to the Letter to the Editor by Rob Armstrong.

Six RH, Young DR, Myers MR, Mahabir SP.

Parasit Vectors. 2017 Apr 26;10(1):207. doi: 10.1186/s13071-017-2142-4.

15.

COKE LIVe: recurrent vasculitis secondary to cocaine contaminated with levamisole.

Sandys V, Mahabir S, Byrne D, Wynne B.

Acute Med. 2016;15(4):206-208. Review.

PMID:
28112289
16.

A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis.

Michels GM, Ramsey DS, Walsh KF, Martinon OM, Mahabir SP, Hoevers JD, Walters RR, Dunham SA.

Vet Dermatol. 2016 Dec;27(6):478-e129. doi: 10.1111/vde.12376. Epub 2016 Sep 19.

PMID:
27647569
17.

A blinded, randomized, placebo-controlled trial of the safety of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in client-owned dogs with atopic dermatitis.

Michels GM, Walsh KF, Kryda KA, Mahabir SP, Walters RR, Hoevers JD, Martinon OM.

Vet Dermatol. 2016 Dec;27(6):505-e136. doi: 10.1111/vde.12364. Epub 2016 Sep 19.

PMID:
27647513
18.

Comparative speed of kill of sarolaner (Simparica™ Chewables) and fluralaner (Bravecto(®)) against induced infestations of Amblyomma americanum on dogs.

Six RH, Young DR, Myers MR, Mahabir SP.

Parasit Vectors. 2016 Jul 18;9(1):399. doi: 10.1186/s13071-016-1684-1.

19.

Is nonalcoholic fatty liver disease driving the increased incidence of liver cancer?

Mahabir S.

Cancer. 2016 Jul 15;122(14):2277-8. doi: 10.1002/cncr.30055. Epub 2016 May 3. No abstract available.

20.

Efficacy of a novel oral formulation of sarolaner (Simparica™) against four common tick species infesting dogs in Europe.

Geurden T, Becskei C, Grace S, Strube C, Doherty P, Liebenberg J, Mahabir SP, Slootmans N, Lloyd A, Six RH.

Vet Parasitol. 2016 May 30;222:33-6. doi: 10.1016/j.vetpar.2016.03.024. Epub 2016 Apr 1.

21.

Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica™) in the treatment of naturally occurring flea and tick infestations in dogs presented as veterinary patients in Europe.

Becskei C, De Bock F, Illambas J, Mahabir SP, Farkas R, Six RH.

Vet Parasitol. 2016 May 30;222:49-55. doi: 10.1016/j.vetpar.2016.02.007. Epub 2016 Mar 16.

22.

Efficacy of sarolaner, a novel oral isoxazoline, against two common mite infestations in dogs: Demodex spp. and Otodectes cynotis.

Six RH, Becskei C, Mazaleski MM, Fourie JJ, Mahabir SP, Myers MR, Slootmans N.

Vet Parasitol. 2016 May 30;222:62-6. doi: 10.1016/j.vetpar.2016.02.027. Epub 2016 Mar 4.

23.

Evaluation of the speed of kill, effects on reproduction, and effectiveness in a simulated infested-home environment of sarolaner (Simparica™) against fleas on dogs.

Six RH, Becskei C, Carter L, Gale B, Young DR, Mahabir SP, Chapin S, Myers MR.

Vet Parasitol. 2016 May 30;222:23-7. doi: 10.1016/j.vetpar.2016.02.026. Epub 2016 Mar 4.

24.

Determination of the effective dose of a novel oral formulation of sarolaner (Simparica™) for the treatment and month-long control of fleas and ticks on dogs.

McTier TL, Six RH, Fourie JJ, Pullins A, Hedges L, Mahabir SP, Myers MR.

Vet Parasitol. 2016 May 30;222:12-7. doi: 10.1016/j.vetpar.2016.02.016. Epub 2016 Feb 17.

25.

Efficacy and safety of sarolaner (Simparica™) against fleas on dogs presented as veterinary patients in the United States.

Cherni JA, Mahabir SP, Six RH.

Vet Parasitol. 2016 May 30;222:43-8. doi: 10.1016/j.vetpar.2015.12.022. Epub 2015 Dec 28.

26.

Evaluation of the effectiveness of a novel oral formulation of sarolaner (Simparica™) for the treatment and control of fleas on dogs.

Six RH, Geurden T, Packianathan R, Colgan S, Everett WR, Grace S, Hodge A, Mahabir SP, Myers MR, Slootmans N, Davis K.

Vet Parasitol. 2016 May 30;222:18-22. doi: 10.1016/j.vetpar.2016.02.015. Epub 2016 Feb 17.

27.

Efficacy of a novel oral formulation of sarolaner (Simparica™) against five common tick species infesting dogs in the United States.

Six RH, Everett WR, Young DR, Carter L, Mahabir SP, Honsberger NA, Myers MR, Holzmer S, Chapin S, Rugg JJ.

Vet Parasitol. 2016 May 30;222:28-32. doi: 10.1016/j.vetpar.2015.12.023. Epub 2015 Dec 28.

28.

Evaluation of the speed of kill of sarolaner (Simparica™) against induced infestations of three species of ticks (Amblyomma maculatum, Ixodes scapularis, Ixodes ricinus) on dogs.

Six RH, Geurden T, Carter L, Everett WR, McLoughlin A, Mahabir SP, Myers MR, Slootmans N.

Vet Parasitol. 2016 May 30;222:37-42. doi: 10.1016/j.vetpar.2016.02.014. Epub 2016 Feb 17.

29.

Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica™), for the treatment of sarcoptic mange in dogs.

Becskei C, De Bock F, Illambas J, Cherni JA, Fourie JJ, Lane M, Mahabir SP, Six RH.

Vet Parasitol. 2016 May 30;222:56-61. doi: 10.1016/j.vetpar.2016.02.017. Epub 2016 Feb 20.

30.

Comparative speed of kill after treatment with Simparica™ (sarolaner) and Advantix®(imidacloprid + permethrin) against induced infestations of Dermacentor reticulatus on dogs.

Becskei C, Geurden T, Erasmus H, Cuppens O, Mahabir SP, Six RH.

Parasit Vectors. 2016 Feb 24;9:104. doi: 10.1186/s13071-016-1377-9.

31.

Comparative speed of kill of oral treatments with Simparica™ (sarolaner) and Bravecto®(fluralaner) against induced infestations of Rhipicephalus sanguineus on dogs.

Becskei C, Geurden T, Liebenberg J, Cuppens O, Mahabir SP, Six RH.

Parasit Vectors. 2016 Feb 24;9:103. doi: 10.1186/s13071-016-1376-x.

32.

Efficacy of sarolaner in the prevention of Borrelia burgdorferi and Anaplasma phagocytophilum transmission from infected Ixodes scapularis to dogs.

Honsberger NA, Six RH, Heinz TJ, Weber A, Mahabir SP, Berg TC.

Vet Parasitol. 2016 May 30;222:67-72. doi: 10.1016/j.vetpar.2016.02.010. Epub 2016 Feb 20.

33.

Comparative speed of kill of sarolaner (Simparica) and afoxolaner (NexGard) against induced infestations of Amblyomma americanum on dogs.

Six RH, Everett WR, Chapin S, Mahabir SP.

Parasit Vectors. 2016 Feb 19;9:98. doi: 10.1186/s13071-016-1378-8.

34.

Comparative speed of kill of sarolaner (Simparica) and afoxolaner (NexGard) against induced infestations of Rhipicephalus sanguineus s.l. on dogs.

Six RH, Young DR, Holzmer SJ, Mahabir SP.

Parasit Vectors. 2016 Feb 19;9:91. doi: 10.1186/s13071-016-1375-y.

35.
36.

Comparative speed of kill of sarolaner (Simparica and fluralaner (Bravecto) against induced infestations of Ctenocephalides felis on dogs.

Six RH, Liebenberg J, Honsberger NA, Mahabir SP.

Parasit Vectors. 2016 Feb 19;9:92. doi: 10.1186/s13071-016-1373-0.

37.

Comparative speed of kill of sarolaner (Simparica) and afoxolaner (NexGard) against induced infestations of Ctenocephalides felis on dogs.

Six RH, Liebenberg J, Honsberger NA, Mahabir SP.

Parasit Vectors. 2016 Feb 19;9:90. doi: 10.1186/s13071-016-1372-1.

38.

Comparative speed of kill of sarolaner (Simparica) and afoxolaner (NexGard against induced infestations of Ixodes scapularis on dogs.

Six RH, Young DR, Myers MR, Mahabir SP.

Parasit Vectors. 2016 Feb 15;9:79. doi: 10.1186/s13071-016-1307-x.

39.

IL-31-induced pruritus in dogs: a novel experimental model to evaluate anti-pruritic effects of canine therapeutics.

Gonzales AJ, Fleck TJ, Humphrey WR, Galvan BA, Aleo MM, Mahabir SP, Tena JK, Greenwood KG, McCall RB.

Vet Dermatol. 2016 Feb;27(1):34-e10. doi: 10.1111/vde.12280. Epub 2015 Dec 15.

40.

Early-life exposures to infectious agents and later cancer development.

Vedham V, Verma M, Mahabir S.

Cancer Med. 2015 Dec;4(12):1908-22. doi: 10.1002/cam4.538. Epub 2015 Sep 17. Review.

41.

Low to moderate alcohol consumption on serum vitamin D and other indicators of bone health in postmenopausal women in a controlled feeding study.

Mahabir S, Baer DJ, Pfeiffer RM, Li Y, Watkins BA, Taylor PR.

Eur J Clin Nutr. 2014 Nov;68(11):1267-70. doi: 10.1038/ejcn.2014.191. Epub 2014 Sep 17.

PMID:
25226824
42.

Dietary magnesium and inflammation.

Mahabir S.

Eur J Clin Nutr. 2014 Aug;68(8):970. doi: 10.1038/ejcn.2014.110. Epub 2014 Jun 18. No abstract available.

PMID:
24939436
43.

Prediction of formulation effects on dermal absorption of topically applied ectoparasiticides dosed in vitro on canine and porcine skin using a mixture-adjusted quantitative structure permeability relationship.

Riviere JE, Brooks JD, Collard WT, Deng J, de Rose G, Mahabir SP, Merritt DA, Marchiondo AA.

J Vet Pharmacol Ther. 2014 Oct;37(5):435-44. doi: 10.1111/jvp.12121. Epub 2014 Mar 21.

PMID:
24649911
44.

Strain dependent neurochemical changes induced by embryonic alcohol exposure in zebrafish.

Mahabir S, Chatterjee D, Gerlai R.

Neurotoxicol Teratol. 2014 Jan-Feb;41:1-7. doi: 10.1016/j.ntt.2013.11.001. Epub 2013 Nov 10.

45.

Oral vancomycin desensitisation to treat Clostridium difficile infection in a vancomycin allergic patient.

Mahabir S, Lim RY, Fitzpatrick F, Magee C, Keogan M.

World Allergy Organ J. 2013 Sep 30;6(1):16. doi: 10.1186/1939-4551-6-16.

46.

Maturation of shoaling in two zebrafish strains: a behavioral and neurochemical analysis.

Mahabir S, Chatterjee D, Buske C, Gerlai R.

Behav Brain Res. 2013 Jun 15;247:1-8. doi: 10.1016/j.bbr.2013.03.013. Epub 2013 Mar 18.

47.

Association between diet during preadolescence and adolescence and risk for breast cancer during adulthood.

Mahabir S.

J Adolesc Health. 2013 May;52(5 Suppl):S30-5. doi: 10.1016/j.jadohealth.2012.08.008. Epub 2012 Nov 9. Review.

48.

Growth kinetics of lipid-based nanodiscs to unilamellar vesicles-a time-resolved small angle neutron scattering (SANS) study.

Mahabir S, Small D, Li M, Wan W, Kučerka N, Littrell K, Katsaras J, Nieh MP.

Biochim Biophys Acta. 2013 Mar;1828(3):1025-35. doi: 10.1016/j.bbamem.2012.11.002. Epub 2012 Nov 26.

49.

Assessing resistance against macrocyclic lactones in gastro-intestinal nematodes in cattle using the faecal egg count reduction test and the controlled efficacy test.

De Graef J, Sarre C, Mills BJ, Mahabir S, Casaert S, De Wilde N, Van Weyenberg M, Geldhof P, Marchiondo A, Vercruysse J, Meeus P, Claerebout E.

Vet Parasitol. 2012 Oct 26;189(2-4):378-82. doi: 10.1016/j.vetpar.2012.04.040. Epub 2012 May 9.

PMID:
22647465
50.

Challenges and opportunities in research on early-life events/exposures and cancer development later in life.

Mahabir S, Aagaard K, Anderson LM, Herceg Z, Hiatt RA, Hoover RN, Linet MS, Medina D, Potischman N, Tretli S, Trichopoulos D, Troisi R.

Cancer Causes Control. 2012 Jun;23(6):983-90. doi: 10.1007/s10552-012-9962-5. Epub 2012 Apr 25.

PMID:
22527169

Supplemental Content

Loading ...
Support Center